ECE2006 - Society for Endocrinology

8th European Congress of EndocrinologyMonday 3 April 2006 - continuedS82 15.20 Medical treatmentC Marcocci (Pisa, Italy)S83 15.50 Alternative immunomodulatory therapiesfor Graves' ophthalmopathyJ Banga (London, UK)S84 16.20 Ophthalmic management of thyroid eyediseaseG Rose (London, UK)14.50-16.50 Basic Workshop:In vivo imaging of signallingHALL 1Chair: TBAS85 14.50 OPT: a novel wholemount imagingtechnology for visualising gene andprotein expressionS Wedden (Edinburgh, UK)S86 15.30 A mouse reporting on estrogen receptor(ER) transcriptional activity to understandthe complexities of female physiology inmammalsA Maggi (Milan, Italy)S87 16.10 Micro PET-ing in miceM Kreissl (Wuerzburg, Germany)14.50-16.50 Oral Communications 4:Diabetes and metabolismOC25 14.50OC26 15.05OC27 15.20FORTH ROOMChairs: R Corcoy (Barcelona, Spain) &H Romijn (Leiden, The Netherlands)Cannabinoids increase AMP-activatedprotein kinase (AMPK) enzyme activity inthe hypothalamus and heart via differentsignalling pathways - studies in CB1knockout animalsB Kola, M Christ-Crain, G Wittman,C Leontiou, A Grossman, C Fekete &M KorbonitsNeuropeptide S is a novel peptide, whichpotently stimulates the hypothalamopituitary-adrenalaxis and inhibits foodintakeKL Smith, M Patterson, WS Dhillo, SR Patel,NM Semjonous, JV Gardiner, MA Ghatei &SR BloomA selective increase in adipose 11β-HSD1expression in corticosterone-treatedPOMC-null mice is associated withdevelopment of metabolic syndromeZM Michailidou, APC Coll, NMM Morton,CJ Kenyon, S O'Rahilly, JR Seckl &KE ChapmanOC28 15.35OC29 15.50OC30 16.05OC31 16.20OC32 16.3516.50-17.30 TEA11β-Hydroxysteroid dehydrogenase type1 oxoreductase activity is increased inpatients with alcoholic chronic liverdisease: the key to the phenotype of thealcoholic pseudo-Cushing's state?A Ahmed, S Saksena, E Elias & PM StewartA choline deficient diet in mice preventshigh fat diet-induced insulin resistance inspite of more severe fatty liver diseasePJ Raubenheimer, MJ Nyirenda & BR WalkerThe release of the adipocytokine visfatinis regulated by glucose and insulinDG Haider, G Schaller, S Kapiotis, C Maier,A Luger & M WolztComparative analysis of the effects ofdehydroepiandrosterone (DHEA) onwhite and brown pre-adipocyteproliferation/differentiationSPL Rice, E Wang, MF Scanlon, M Ludgate &DA ReesThe in vitro effects of resistin on theinnate immune signalling pathway inisolated human subcutaneous adipocytesCM Kusminski, NF da Silva, AL Harte, S Kumar& PG McTernanHALL 317.30-18.15 Plenary 2S9CLYDE AUDITORIUMChair: B Ake Bengtsson (Sweden)Statins and rhabdomyolysisM Law (London, UK)18.30-20.00 Pfizer Satellite Symposium 2Clinical management ofacromegaly: applying 10 yearsof human experience withpegvisomantCLYDE AUDITORIUMFREE EVENINGPROGRAMMEwww.ece2006.com 21